Some types are safe for long-term use under medical guidance
Theyre subject to strict standards for purity and potency beyond what normal drugs are held to, on the basis that they are derived from living organisms - which would preclude compounding pharmacy formulations that weve seen with semaglutide and tirzepatide
She also advises gradual weight loss to avoid shocking the system
In contrast, SGLT2 inhibitor monotherapy is not likely to provide sufcient weight loss for treatment of obesity per se, but could have other benefts in obese patients with comorbidities such as atherosclerotic cardiovascular disease, heart failure, or renal disease
FDA approval confirms its effectiveness, but its not a miracle drug
Annual diabetes diagnosis rates reach 1.2 million new cases, highlighting the ongoing expansion of this epidemic ^35